DOSSIER · UPDATED 18 JUN 2026

Contineum Therapeutics

Contineum Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation and immunology (NI&I) indications with high unmet need.…

contineum-tx.com ↗Claim this profile

Founded: 2017
Headcount: 43
Open roles: 0
Last raised: Post Ipo Equity · $99M

SECTION I · THE BRIEF

Inside Contineum Therapeutics

Brief #47332Updated 18 JUN 2026SAN DIEGOMEDICAL ORGANIZATIONSPOST IPO EQUITY

Employbl Dossier

Contineum Therapeutics

Founded: 2017
Headcount: 43
Open roles: 0
Last raised: Post Ipo Equity · $99M

Section II · Premium ProfileMembers only

01Engineering interview process at Contineum TherapeuticsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Contineum Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Brian Stearns

Daniel Lorrain

OPEN ROLES

Hiring at Contineum Therapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $211,224,992